Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 6

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 6
---
 from certain corporate governance requirements that provide protections to stockholders”and
“Controlled Company Exemption.”In addition, upon the consummation of this offering, Society Pass Incorporated will
control 78.877.5% of the voting power of the Company’s outstanding voting securities.

|                                           |     | Per Share |     | Total |
|:------------------------------------------|:----|:----------|:----|:------|
| Public offering price                     |     | $         |     | $     |
| Underwriting discounts and commissions(1) |     | $         |     | $     |
| Proceeds to us, before expenses(2)        |     | $         |     | $     |

(1) We have agreed to pay Cathay Securities, Inc.,
as the representative (the “Representative”) of the underwriters named in this prospectus, an underwriting discount equal
to seven percent (7.0%) of the gross proceeds of the offering.

(2) The amount of offering proceeds to us presented in this table does not give effect to the exercise of the over-allotment option issued to the Underwriter.

We have also agreed to issue to the
Representative, on the closing date of this offering, warrants in an amount equal to seven percent (7.0%) of the aggregate number of shares
of Common Stock sold by us in this offering and exercisable at a price per share equal to one hundred and twenty-five percent (125%) of
the public offering price (the “Underwriter’s Warrants”). In addition, we have agreed to pay a non-accountable expense allowance to the Representative equal to 1% of the gross proceeds received at the closing of the offering.For a description of compensation
to be received by the Underwriter, see “Underwriting” for more information.

(2) The amount of offering proceeds to us presented in this table does not give effect to the exercise of the over-allotment option issued to the Underwriter.

We have granted the underwriters an option, exercisable
for up to 45 days from the date of this prospectus, to purchase a maximum of 405450,000 shares of Common Stock
(equal to fifteen percent (15%) of the aggregate number of shares of Common Stock sold in this offering) on the same terms as the other
shares of Common Stock being purchased by the underwriters from us.

This offering is being conducted on a firm commitment
basis. The underwriters are obligated to take and purchase